As of 2025-11-16, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 1.75 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 6.14 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -71.5%.
The range of the Relative Valuation is (0.10) - 4.13 CAD.
| Range | Selected | |
| Trailing P/E multiples | 2.8x - 4.3x | 3.6x |
| Forward P/E multiples | 31.2x - 41.2x | 36.2x |
| Fair Price | (0.10) - 4.13 | 1.75 |
| Upside | -101.6% - -32.8% | -71.5% |
| Date | P/E |
| 2025-11-14 | -175.22 |
| 2025-11-13 | -175.50 |
| 2025-11-12 | -178.07 |
| 2025-11-11 | -177.79 |
| 2025-11-10 | -172.65 |
| 2025-11-07 | -172.65 |
| 2025-11-06 | -173.22 |
| 2025-11-05 | -166.66 |
| 2025-11-04 | -165.52 |
| 2025-11-03 | -166.66 |
| 2025-10-31 | -166.66 |
| 2025-10-30 | -165.52 |
| 2025-10-29 | -164.09 |
| 2025-10-28 | -166.37 |
| 2025-10-27 | -167.23 |
| 2025-10-24 | -166.37 |
| 2025-10-23 | -167.51 |
| 2025-10-22 | -165.52 |
| 2025-10-21 | -167.23 |
| 2025-10-20 | -167.80 |
| 2025-10-17 | -164.94 |
| 2025-10-16 | -164.94 |
| 2025-10-15 | -164.09 |
| 2025-10-14 | -164.09 |
| 2025-10-10 | -164.66 |
| 2025-10-09 | -168.08 |
| 2025-10-08 | -167.51 |
| 2025-10-07 | -166.94 |
| 2025-10-06 | -168.65 |
| 2025-10-03 | -166.94 |
| 2025-10-02 | -166.37 |
| 2025-10-01 | -169.22 |
| 2025-09-30 | -167.80 |
| 2025-09-29 | -168.94 |
| 2025-09-26 | -169.22 |
| 2025-09-25 | -173.51 |
| 2025-09-24 | -173.22 |
| 2025-09-23 | -172.36 |
| 2025-09-22 | -176.36 |
| 2025-09-19 | -177.79 |
| 2025-09-18 | -176.93 |
| 2025-09-17 | -177.79 |
| 2025-09-16 | -179.78 |
| 2025-09-15 | -181.21 |
| 2025-09-12 | -180.93 |
| 2025-09-11 | -183.49 |
| 2025-09-10 | -182.64 |
| 2025-09-09 | -183.49 |
| 2025-09-08 | -184.06 |
| 2025-09-05 | -183.78 |